Article
Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions.
PloS one - 1 Jan 2014
Hervy Martial, Weber Jennifer L, Pecheul Marylene, Dolley-Sonneville Paula, Henry David, Zhou Yue, Melkoumian Zara
Abstract excerpt
Human mesenchymal stem cells (hMSCs) present an attractive target for cell therapy given their wide availability, immunomodulatory properties, and multipotent nature for differentiation into chondrocytes, osteocytes, and adipocytes. With the progression of hMSC clinical studies, there is an increasing demand for development of technologies that enable efficient cell scale-up into clinically relevant quantities....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
